Captopril

CAS No. 62571-86-2

Captopril( SA 333 | SQ 14,225 )

Catalog No. M15369 CAS No. 62571-86-2

Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 36 In Stock
100MG 43 In Stock
200MG 53 In Stock
500MG 73 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Captopril
  • Note
    Research use only, not for human use.
  • Brief Description
    Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE).
  • Description
    Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SA 333 | SQ 14,225
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    ACE
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    62571-86-2
  • Formula Weight
    217.29
  • Molecular Formula
    C9H15NO3S
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 43 mg/mL (197.89 mM); Water: 2 mg/mL (9.2 mM); DMSO: 43 mg/mL (197.89 mM)
  • SMILES
    O=C([C@H]1N(C([C@H](C)CS)=O)CCC1)O
  • Chemical Name
    (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Andujar-Sanchez M, et al. FEBS Lett. 2007 Jul 24;581(18):3449-54.
molnova catalog
related products
  • Prosaikogenin G

    Prosaikogenin G is a compound isolated from the roots of Buleurum bicaule Helm (Apiaceae) and id a derivative of Saikosaponin d in the gastrointestinal tract, exhibiting a significant inhibitory effect on angiotensin II-induced proliferation of mesangial

  • Pomisartan

    Pomisartan (BIBR-363) is a small molecule angiotensin type 1 receptor (AT1R) antagonist that is used in the treatment of cardiovascular disease, studying heart failure and hypertensio

  • L162389

    L162389 is an orally active and potent angiotensin II receptor antagonist with a balanced affinity for AT1 and AT2 receptor subtypes that stimulates the conversion of phosphatidylinositol.